Emergent BioSolutions Inc.EBSNYSE
Loading
Year-over-year gross profit growth rate
Percentile
P8
Near historical low
vs 5Y Ago
-0.8x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -77.69% |
| Q3 2025 | 129.65% |
| Q2 2025 | -49.16% |
| Q1 2025 | -12.53% |
| Q4 2024 | -16.87% |
| Q3 2024 | 350.69% |
| Q2 2024 | -146.52% |
| Q1 2024 | -16.78% |
| Q4 2023 | 83.12% |
| Q3 2023 | -25.12% |
| Q2 2023 | 607.82% |
| Q1 2023 | -121.26% |
| Q4 2022 | 123.68% |
| Q3 2022 | 168.95% |
| Q2 2022 | -82.02% |
| Q1 2022 | -75.28% |
| Q4 2021 | 580.89% |
| Q3 2021 | -48.01% |
| Q2 2021 | -37.18% |
| Q1 2021 | -45.92% |
| Q4 2020 | 96.68% |
| Q3 2020 | -16.68% |
| Q2 2020 | 195.24% |
| Q1 2020 | -63.86% |
| Q4 2019 | 35.24% |
| Q3 2019 | 91.59% |
| Q2 2019 | 48.96% |
| Q1 2019 | -51.34% |
| Q4 2018 | 60.92% |
| Q3 2018 | -38.93% |
| Q2 2018 | 220.35% |
| Q1 2018 | -68.59% |
| Q4 2017 | 31.68% |
| Q3 2017 | 104.87% |
| Q2 2017 | -19.55% |
| Q1 2017 | -41.52% |
| Q4 2016 | 13.29% |
| Q3 2016 | 124.79% |
| Q2 2016 | -36.87% |
| Q1 2016 | -51.14% |